Input interpretation
suramin
Chemical names and formulas
![formula | C_51H_34N_6Na_6O_23S_6 name | suramin IUPAC name | hexasodium 8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4, 6, 8-trisulfonatonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1, 3, 5-trisulfonate alternate names | germanin | moranyl | naganine mass fractions | C (carbon) 42.9% | H (hydrogen) 2.4% | N (nitrogen) 5.88% | Na (sodium) 9.65% | O (oxygen) 25.7% | S (sulfur) 13.5%](../image_source/d2a215cb4c19caafc380c951023961ff.png)
formula | C_51H_34N_6Na_6O_23S_6 name | suramin IUPAC name | hexasodium 8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4, 6, 8-trisulfonatonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1, 3, 5-trisulfonate alternate names | germanin | moranyl | naganine mass fractions | C (carbon) 42.9% | H (hydrogen) 2.4% | N (nitrogen) 5.88% | Na (sodium) 9.65% | O (oxygen) 25.7% | S (sulfur) 13.5%
Structure diagram
Structure diagram
vertex count | 92 edge count | 99 Schultz index | 229646 Wiener index | 54019 Hosoya index | (data not available) Balaban index | 0.8008
Basic properties
molar mass | 1429.2 g/mol phase | solid (at STP)
Units
Hydrophobicity and permeability properties
predicted LogP hydrophobicity | -0.12 predicted LogS | -5.17
Basic drug properties
approval status | approved | small molecule drug categories | antinematodal agent | antineoplastic agent | trypanocidal agent dosage forms | intravenous: injection, powder, for solution
brand names | antrypol | belganyl | farma | fourneau | germanin | moranyl | naganil | naganin | naganine | naganol | naphuride
Chemical identifiers
![CAS number | 129-46-4 Beilstein number | 3694087 PubChem CID number | 8514 PubChem SID number | 7890636 SMILES identifier | CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] InChI identifier | InChI=1/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69, 70)71)35-21-33(81(63, 64)65)23-43(45(35)37)85(75, 76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72, 73)74)36-22-34(82(66, 67)68)24-44(46(36)38)86(78, 79)80;;;;;;/h3-24H, 1-2H3, (H, 54, 60)(H, 55, 61)(H, 56, 58)(H, 57, 59)(H2, 52, 53, 62)(H, 63, 64, 65)(H, 66, 67, 68)(H, 69, 70, 71)(H, 72, 73, 74)(H, 75, 76, 77)(H, 78, 79, 80);;;;;;/q;6*+1/p-6/fC51H34N6O23S6.6Na/h52-57H;;;;;;/q-6;6m InChI key | FIAFUQMPZJWCLV-YJZMAWKGCG EU number | 204-949-3 RTECS number | QM7000000 NSC number | 34936](../image_source/cc817d01ad29a36b5a1e3f7cea4ccf96.png)
CAS number | 129-46-4 Beilstein number | 3694087 PubChem CID number | 8514 PubChem SID number | 7890636 SMILES identifier | CC1=C(C=C(C=C1)C(=O)NC2=C3C(=CC(=CC3=C(C=C2)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])NC(=O)C4=CC(=CC=C4)NC(=O)NC5=CC=CC(=C5)C(=O)NC6=C(C=CC(=C6)C(=O)NC7=C8C(=CC(=CC8=C(C=C7)S(=O)(=O)[O-])S(=O)(=O)[O-])S(=O)(=O)[O-])C.[Na+].[Na+].[Na+].[Na+].[Na+].[Na+] InChI identifier | InChI=1/C51H40N6O23S6.6Na/c1-25-9-11-29(49(60)54-37-13-15-41(83(69, 70)71)35-21-33(81(63, 64)65)23-43(45(35)37)85(75, 76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72, 73)74)36-22-34(82(66, 67)68)24-44(46(36)38)86(78, 79)80;;;;;;/h3-24H, 1-2H3, (H, 54, 60)(H, 55, 61)(H, 56, 58)(H, 57, 59)(H2, 52, 53, 62)(H, 63, 64, 65)(H, 66, 67, 68)(H, 69, 70, 71)(H, 72, 73, 74)(H, 75, 76, 77)(H, 78, 79, 80);;;;;;/q;6*+1/p-6/fC51H34N6O23S6.6Na/h52-57H;;;;;;/q-6;6m InChI key | FIAFUQMPZJWCLV-YJZMAWKGCG EU number | 204-949-3 RTECS number | QM7000000 NSC number | 34936
Toxicity properties
RTECS classes | drug